Frederic Bedin
21Patents
4h-index
17Co-inventors
60Inventor score
Filing activity: Feb 6, 1995 → Mar 6, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6001987A | Isolated nucleotide sequences associated with Multiple sclerosis | Chemistry; Metallurgy | 15 | Expired |
| US6342383B1 | Cell lines and viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5800980A | Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6184025A | Viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5871996A | Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5962217A | MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5871745A | Multiple sclerosis related virus | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6582703B2 | Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting | Chemistry; Metallurgy | 4 | Expired |
| US7674888B2 | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes | Chemistry; Metallurgy | 4 | Active |
| US7479386B2 | HXHV virus, nucleic material, peptide material and uses | Chemistry; Metallurgy | 1 | Expired |
| US6579526B1 | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes | Chemistry; Metallurgy | 1 | Expired |
| US10281470B2 | Method and kit for determining the probability that a patient will develop a severe case of dengue | Emerging Cross-Sectional Technologies | 0 | Active |
| US10309965B2 | Method and kit for determining the probability that a patient will develop a severe case of dengue | Emerging Cross-Sectional Technologies | 0 | Active |
| US7771927B1 | Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region | Chemistry; Metallurgy | 0 | Expired |
| US9945857B2 | Method and kit for determining the probability that a patient will develop a severe case of dengue | Emerging Cross-Sectional Technologies | 0 | Active |
| US7932350B2 | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes | Chemistry; Metallurgy | 0 | Active |
| US10823732B2 | Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample | Emerging Cross-Sectional Technologies | 0 | Active |
| US9863948B2 | Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample | Emerging Cross-Sectional Technologies | 0 | Active |
| US9933426B2 | Method and kit for determining the probability that a patient will develop a severe case of dengue | Emerging Cross-Sectional Technologies | 0 | Active |
| US8088910B2 | Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region | Chemistry; Metallurgy | 0 | Active |
| US9778260B2 | Process for the detection and early serotyping of the dengue virus | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.